He further honed his knowledge and skillset in sinus surgery and Neuro-Rhinology through instruction and observerships at prestigious centres of excellence, including the University of Adelaide (Australia), Stanford (USA), Medical University of South Carolina (USA), University of Pittsburgh (USA), and University of Kansas (USA). He also completed a competitive fellowship in Rhinology and Endoscopic Skull Base Surgery at Northwestern University (USA) under the tutelage of Drs. Robert Kern, David Conley, Kevin Welch and Bruce Tan, who are prominent leaders in the field.
Additionally, Dr. Yip is one of the few fellowship trained sinus surgeons in Alberta, and comes from a unique pedigree compared to his counterparts having completed his training in Eastern Canada and the US. He is also an academic leader in sinus and skull base surgery, and is frequently invited as a speaker and surgical instructor at national and international conferences and endoscopic sinus/skull base courses.
With a foundation of rigorous training and a commitment to cutting-edge medical practices, Dr. Yip offers personalized and comprehensive care that addresses a wide spectrum of nasal, sinus, and skull base conditions.
At the heart of Dr. Yip’s practice is a patient-centered philosophy and commitment to personalized medicine. He tailors each treatment to meet the specific needs and goals of his patients, ensuring that every individual receives the highest quality of care.
He co-runs the Western Canadian Sinus Course with Drs. Andrew Thamboo (UBC) and Erin Wright (University of Alberta), helping practicing otolaryngologists improve their knowledge and skills. This is one of many examples illustrating Dr. Yip’s continued contribution to the medical community through education and mentorship.
Cottrell J, Yip J, Chan Y, Chin CJ, Damji A, de Almeida J, Desrosiers M, Janjua A, Kilty S, Lee JM, Macdonald K, Meen E, Rudmik L, Sommer D, Sowerby L, Tewfik M, Vescan AD, Witterick IJ, Wright E, Monteiro E. Quality indicators for the diagnosis and management of chronic rhinosinusitis. Int Forum Allergy Rhinology. 2018 Dec;8(12):1369-1379. doi: 10.1002/alr.22161. Impact Factor: 2.35. Co-author or Collaborator.
The significance of this publication rests on the fact that it is the first publication to develop quality indicators in the diagnosis and management of chronic rhinosinusitis. These indicators can serve multiple purposes, including documenting the quality of care; comparing institutions and providers; prioritizing quality improvement initiatives; supporting accountability, regulation, and accreditation; and determining pay-for-performance initiatives.
Lee JM, McKnight CL, Aves T, Yip J, Grewal AS, Gupta S. Nasal nitric oxide as a marker of sinus mucosal health in patients with nasal polyposis. Int Forum Allergy Rhinol. 2015 Oct 1;5(10):894-9. Impact Factor: 2.35. Co-author or Collaborator.
This was the first ever study demonstrating that nasal nitric oxide (nNO) may be a marker of sinus mucosal health in patients with nasal polyposis. The study required a significant amount of coordination to measure nNO and follow-up on patients in a prospective fashion before and after sinus surgery. The results advance the field of rhinology as a whole as it improves our understanding of the role of nNO in chronic rhinosinusitis.
Yip J, Yao CM, Lee JM. State of the art: a systematic review of the surgical management of aspirin exacerbated respiratory disease. Am J Rhinol Allergy. 2014 Nov 1;28(6):493-501. Impact Factor: 1.955. Co-author or Collaborator.
Aspirin exacerbated respiratory disease (AERD) has previously been known to be one of the most difficult subtypes of chronic rhinosinusitis to manage. However, there had never been a systematic review critically evaluating the literature to determine the effectiveness of endoscopic sinus surgery (ESS) in this population. This paper was able to demonstrate clearly that AERD patients achieve the same level of subjective improvement following ESS as non-AERD patients. However, revision rates are higher and this can be used to properly counsel patients prior to surgery.
Bell C, Thamboo A, Monteiro E, Yip J. Prescribing Practices and Barriers of Biologics for Chronic Rhinosinusitis Amongst Otolaryngologists. Laryngoscope. 2024 Aug;134(8):3493-3498.
The article describes a survey-based study of Canadian Otolaryngologists aimed at understanding their prescribing practices and barriers for biologics for chronic rhinosinusitis, as well as patient factors which guide prescriber decision making. It was also a featured article in Laryngoscope in August 2024.
Samargandy S, Grose E, Chan Y, Monteiro E, Lee JM, Yip J. Medical and surgical treatment outcomes in patients with chronic rhinosinusitis and immunodeficiency: a systematic review. Int Forum Allergy Rhinology. 2021 Feb;11(2):162-173.
Yip J, Macdonald KI, Lee J, Witterick IJ, Zadeh G, Gentili F and Vescan AD. The inferior turbinate flap in skull base reconstruction. Journal of Otolaryngology- Head & Neck Surgery. 2013 Jan 31;42(4):6.
This paper is often cited to describe the use of a posterior pedicle inferior turbinate flap, a local vascularized option, in skull base reconstruction when the nasoseptal flap is no longer an option.
